CTY · ISSUER CIK 2143850
CITY THERAPEUTICS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 3 CITY THERAPEUTICS, INC. insiders reported $6.1M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was ARCH Venture Partners XII, LLC (10% Owner), with $3.1M.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$6.1MInsider buying
$0.00Insider selling
+$6.1MNet open-market
Oct 19, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202617:38 | Oct 19, 2026 | CTY | 10% Owner · +5 joint | P · Buy | $18.00 | +170,000 | 13,692,507 | +1% | +$3.1M | -19.6% | +23.0% |
| Oct 19, 202617:38 | Oct 19, 2026 | CTY | 10% Owner · +5 joint | C · Convert | — | +10,804,215 | 13,522,507 | +397% | — | ||
| Oct 19, 202617:37 | Oct 19, 2026 | CTY | Director, 10% Owner | P · Buy | $18.00 | +170,000 | 13,692,507 | +1% | +$3.1M | -19.6% | +23.0% |
| Oct 19, 202617:37 | Oct 19, 2026 | CTY | Director, 10% Owner | C · Convert | — | +10,804,215 | 13,522,507 | +397% | — | ||
| Oct 19, 202617:36 | Oct 19, 2026 | CTY | Director | C · Convert | — | +610,759 | 1,470,692 | +71% | — |